Ptc Therapeutics Inc (PTCT)

07:32 AM

What To Expect From PTC Therapeutics Inc (PTCT) Q3 2025 Earnings - GuruFocus

07:32 AM

06:19 AM

How PTC Therapeutics Inc. stock compares to growth peersDividend Hike & Safe Capital Growth Plans - newser.com

06:19 AM

05:20 AM

Detecting support and resistance levels for PTC Therapeutics Inc.2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com

05:20 AM

05:07 AM

How to read the order book for PTC Therapeutics Inc.Weekly Earnings Recap & Real-Time Market Sentiment Alerts - newser.com

05:07 AM

04:53 AM

Wolverine Asset Management LLC Trims Stake in PTC Therapeutics, Inc. $PTCT - MarketBeat

04:53 AM

04:39 AM

PTC Therapeutics, Inc. $PTCT Stake Lessened by Pinnacle Associates Ltd. - MarketBeat

04:39 AM

04:24 AM

How PTC Therapeutics Inc. stock benefits from global expansion2025 Volume Leaders & Verified Entry Point Signals - newser.com

04:24 AM

03:39 AM

PTC Therapeutics, Inc. $PTCT Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat

03:39 AM

Nov 02, 2025

Is PTC Therapeutics Inc. stock a top pick in earnings season2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Brighton Jones LLC Invests $226,000 in PTC Therapeutics, Inc. $PTCT - MarketBeat

Nov 02, 2025

Nov 02, 2025

Can PTC Therapeutics Inc. stock reach $100 price targetWeekly Market Outlook & Daily Volume Surge Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Published on: 2025-11-02 01:56:33 - newser.com

Nov 02, 2025

Nov 02, 2025

Is PTC Therapeutics Inc. (BH3) stock safe for risk averse investorsJuly 2025 Snapshot & Fast Moving Stock Watchlists - newser.com

Nov 02, 2025

Nov 02, 2025

PTC Therapeutics submits NDA for Friedreich ataxia treatment vatiquinone - MSN

Nov 02, 2025

Nov 01, 2025

PTC Therapeutics (NASDAQ:PTCT) Director Sells $1,088,787.00 in Stock - MarketBeat

Nov 01, 2025

Nov 01, 2025

PTC Therapeutics Hits New 52-Week High of $69.88, Up 81.1% - Markets Mojo

Nov 01, 2025

Nov 01, 2025

Why PTC Therapeutics Inc. (BH3) stock is trending on social media2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com

Nov 01, 2025

Nov 01, 2025

AlphaQuest LLC Raises Stake in PTC Therapeutics, Inc. $PTCT - MarketBeat

Nov 01, 2025

Nov 01, 2025

Published on: 2025-11-01 00:56:06 - newser.com

Nov 01, 2025

Oct 31, 2025

Insider Sell: Emma Reeve Sells 15,666 Shares of PTC Therapeutics Inc (PTCT) - GuruFocus

Oct 31, 2025

Oct 31, 2025

PTC Therapeutics Inc expected to post a loss of $1.37 a shareEarnings Preview - TradingView

Oct 31, 2025

Oct 31, 2025

Reeve Emma, director at Ptc Therapeutics, sells $1.08 million in shares - Investing.com Australia

Oct 31, 2025

Oct 31, 2025

Reeve Emma, director at Ptc Therapeutics, sells $1.08 million in shares By Investing.com - Investing.com South Africa

Oct 31, 2025

Oct 31, 2025

PTC Therapeutics (NASDAQ:PTCT) Hits New 12-Month HighWhat's Next? - MarketBeat

Oct 31, 2025

Oct 31, 2025

Ptc Therapeutics stock hits 52-week high at 69.53 USD By Investing.com - Investing.com Australia

Oct 31, 2025

Oct 31, 2025

How Investors May Respond To PTC Therapeutics (PTCT) Analysts' Optimism on Sephience Launch Momentum - Sahm

Oct 31, 2025

Oct 31, 2025

2025-10-31 | PTC Therapeutics to Participate at Upcoming Investor Conferences | NDAQ:PTCT | Press Release - Stockhouse

Oct 31, 2025

Oct 31, 2025

PTC Therapeutics Inc. stock prediction for this weekWeekly Trend Recap & Low Risk Entry Point Guides - newser.com

Oct 31, 2025

Oct 31, 2025

Will PTC Therapeutics Inc. (BH3) stock attract long term capital inflowsJuly 2025 Sector Moves & Community Consensus Trade Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

PTC Therapeutics (NASDAQ:PTCT) NASDAQ Composite Leads Biotech - Kalkine Media

Oct 31, 2025

Oct 31, 2025

How to forecast PTC Therapeutics Inc. trends using time seriesWall Street Watch & Technical Entry and Exit Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

Ptc Therapeutics stock hits 52-week high at 69.53 USD - Investing.com

Oct 30, 2025

Oct 30, 2025

How Recent Developments Are Shaping the PTC Therapeutics Investment Story - Yahoo Finance

Oct 30, 2025

Oct 29, 2025

PTC Therapeutics (PTCT) to Release Earnings on Tuesday - MarketBeat

Oct 29, 2025

Oct 29, 2025

Published on: 2025-10-29 06:46:31 - newser.com

Oct 29, 2025

Oct 29, 2025

PTC Therapeutics, Inc. $PTCT Shares Sold by Allianz Asset Management GmbH - MarketBeat

Oct 29, 2025

Oct 29, 2025

Sector ETF performance correlation with PTC Therapeutics Inc.July 2025 Patterns & Weekly High Momentum Picks - newser.com

Oct 29, 2025

Oct 28, 2025

Jefferies Maintains PTC Therapeutics (PTCT) Buy Recommendation - Nasdaq

Oct 28, 2025

Oct 28, 2025

Huntington’s Disease | Clinical Landscape, Key Companies, Therapeutic Assessment, Treatment Algorithms, and Pipeline Insights – featuring leading players such as Hoffmann-La Roche, PTC Therapeutics, A - Barchart.com

Oct 28, 2025

Oct 28, 2025

PD-1 and PD-L1 Inhibitors Clinical Landscape, Key Companies, Therapeutic Evaluation, Treatment Approaches, and Pipeline Insights | Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals - Barchart.com

Oct 28, 2025

Oct 28, 2025

Bevacizumab: Clinical Overview, Key Companies, Therapeutic Insights, Treatment Strategies, and Pipeline Analysis | Hoffmann-La Roche, PTC Therapeutics, Annexon, Alnylam Pharmaceuticals, Neuvivo, BPG B - Barchart.com

Oct 28, 2025

Oct 28, 2025

Published on: 2025-10-28 14:58:18 - fcp.pa.gov.br

Oct 28, 2025

Oct 28, 2025

Bank of America Securities Lifts PT on PTC Therapeutics (PTCT) to $87 From $76 - Insider Monkey

Oct 28, 2025

Oct 28, 2025

PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - sharewise.com

Oct 28, 2025